Literature DB >> 19326996

CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection.

Charles H Cook1, Li Chen, Jin Wen, Peter Zimmerman, Yingxue Zhang, Joanne Trgovcich, Yang Liu, Jian-Xin Gao.   

Abstract

Control of acute murine cytomegalovirus (MCMV) infection is dependent upon both innate and adaptive immune responses, relying primarily upon natural killer (NK) and T-cell responses for control. Although CD28/B7 plays a clear role in T-cell responses in many antigen systems including some viral infections, the importance of co-stimulation during MCMV infection is unconfirmed. In addition, recent data suggest that CD28/B7 co-stimulation might also be important to Ly49H+ NK-cell expansion. We therefore hypothesized that CD28/B7 co-stimulation is critical to viral control after MCMV infection, and further that CD28/B7 co-stimulation plays a role in MCMV-specific T- and NK-cell responses. To test these hypotheses, we utilized C57BL/6 mice lacking the co-stimulatory molecules B7-1 and B7-2 or CD28. After primary infection with MCMV, viral titers are significantly elevated in mice lacking CD28 or B7 compared with wild-type mice. Impaired viral control is associated with significant defects in peripheral T-cell responses to MCMV, which appear to be dependent upon CD28/B7 co-stimulation. Abnormal hepatic T-cell responses in CD28(-/-) mice are preceded by impaired MCMV-specific Ly49H+ NK-cell responses. Cytokine evaluations confirm that CD28/B7 co-stimulation is not required for non-specific antiviral responses. We conclude that CD28-mediated co-stimulation is critical for early viral control during acute MCMV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326996      PMCID: PMC2741336          DOI: 10.1089/vim.2008.0080

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  76 in total

1.  The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  Protective effect of early serum from mice after cytomegalovirus infection.

Authors:  T P Araullo-Cruz; M Ho; J A Armstrong
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

3.  Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.

Authors:  R L Simmons; A J Matas; L C Rattazzi; H H Balfour; J R Howard; J S Najarian
Journal:  Surgery       Date:  1977-11       Impact factor: 3.982

4.  Cytotoxic T lymphocyte response to murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz; F A Ennis
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

5.  Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.

Authors:  G J Bancroft; G R Shellam; J E Chalmer
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

6.  Role of T lymphocytes in recovery from murine cytomegalovirus infection.

Authors:  S E Starr; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

7.  Gain of virulence caused by loss of a gene in murine cytomegalovirus.

Authors:  Ivan Bubić; Markus Wagner; Astrid Krmpotić; Tanja Saulig; Sungjin Kim; Wayne M Yokoyama; Stipan Jonjić; Ulrich H Koszinowski
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Role of cytotoxic T lymphocytes in murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz; P A Ennis
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

9.  Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection.

Authors:  Scott H Robbins; Marlowe S Tessmer; Toshifumi Mikayama; Laurent Brossay
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  Modification by adoptive humoral immunity of murine cytomegalovirus infection.

Authors:  J D Shanley; M C Jordan; J G Stevens
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

View more
  12 in total

1.  B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Authors:  Ramon Arens; Andrea Loewendorf; Min J Her; Kirsten Schneider-Ohrum; Geoffrey R Shellam; Edith Janssen; Carl F Ware; Stephen P Schoenberger; Chris A Benedict
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 2.  Cytomegalovirus immune evasion of myeloid lineage cells.

Authors:  Melanie M Brinkmann; Franziska Dağ; Hartmut Hengel; Martin Messerle; Ulrich Kalinke; Luka Čičin-Šain
Journal:  Med Microbiol Immunol       Date:  2015-03-17       Impact factor: 3.402

3.  Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Authors:  Jeffrey J Teoh; Awndre E Gamache; Alyssa L Gillespie; Michael D Stadnisky; Hideo Yagita; Timothy N J Bullock; Michael G Brown
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

4.  Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations.

Authors:  Ramon Arens; Andrea Loewendorf; Anke Redeker; Sophie Sierro; Louis Boon; Paul Klenerman; Chris A Benedict; Stephen P Schoenberger
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

5.  Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Tim Sparwasser; Dirk Homann
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

6.  Occult cytomegalovirus in vivarium-housed mice may influence transplant allograft acceptance.

Authors:  A C Thomas; M R Forster; A A Bickerstaff; P D Zimmerman; B A Wing; J Trgovcich; V K Bergdall; P Klenerman; C H Cook
Journal:  Transpl Immunol       Date:  2010-03-20       Impact factor: 1.708

7.  Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.

Authors:  Meghan R Forster; Joanne Trgovcich; Peter Zimmerman; Alexander Chang; Cortland Miller; Paul Klenerman; Charles H Cook
Journal:  Antiviral Res       Date:  2009-12-11       Impact factor: 5.970

Review 8.  Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion.

Authors:  Niels A W Lemmermann; Kai A Kropp; Christof K Seckert; Natascha K A Grzimek; Matthias J Reddehase
Journal:  J Biomed Biotechnol       Date:  2010-12-26

Review 9.  Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.

Authors:  Hyung-Joon Kwon; Nayoung Kim; Hun Sik Kim
Journal:  Exp Mol Med       Date:  2017-03-31       Impact factor: 8.718

Review 10.  Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.

Authors:  Megat Abd Hamid; Yanchun Peng; Tao Dong
Journal:  Cell Mol Immunol       Date:  2020-05-25       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.